Is bacteriostatic water the same as normal saline (0.9% sodium chloride)?

No. In bacteriostatic water, 0.9% commonly refers to benzyl alcohol; in normal saline, 0.9% refers to sodium chloride. Standard preservative-free saline is not a multidose preserved product, but bacteriostatic sodium chloride products also exist, so preservative status must be determined from the complete label rather than assumed from the percentage alone.

What is the difference between 0.9% and 1.1% benzyl alcohol bacteriostatic water?

Both concentrations appear in USP-referenced labeling. The 0.9% (9 mg/mL) form is the more common one and the concentration this article's reference callout is built on; the 1.1% variant carries a slightly higher preservative load. The USP monograph does not fix a single mandatory concentration, so 0.9% is best described as the common formulation for peptide-reconstitution work rather than a required default.

Can tap water or distilled water be used instead of bacteriostatic water to reconstitute a peptide?

No. Tap and ordinary distilled water are unsuitable because they are not validated sterile and non-pyrogenic and carry no antimicrobial preservative, so they behave like unpreserved water: single-use at best. Bacteriostatic water is manufactured to a sterility and non-pyrogenicity specification, and its benzyl alcohol helps limit microbial growth between punctures, subject to aseptic handling and the labeled discard period rather than any guarantee of ongoing sterility.

How long does an unopened vial last before it is first punctured?

An unopened, properly stored vial is stable until the expiry date printed on its label and batch documentation, which is set by the manufacturer's stability data rather than by the 28-day rule. The general 28-day convention applies after first puncture unless the manufacturer specifies another period; before that, shelf life is governed by the sealed expiry date, commonly one to two years from manufacture depending on the supplier. Always check the printed date on the specific batch.

Is bacteriostatic water a licensed medicine, or can EU researchers buy it as a lab reagent?

Approval is product-specific, not automatic. Specific bacteriostatic-water products carry their own approvals (for example the US Hospira product under NDA 018802); USP or human-use labeling by itself confers neither FDA approval nor an EU marketing authorisation. The research-grade material this product describes is sold as a laboratory reagent for research use only: not marketed as a medicine and not intended for administration to humans or animals. Whether a given RUO reagent may be sold and used depends on its presentation, claims, intended use and applicable member-state law.

Why do benzyl-alcohol-preserved waters carry a neonatal warning?

The 1982 CDC MMWR report and the Gershanik NEJM paper described neonatal cases (Gasping Syndrome) linked to benzyl alcohol, whose metabolite benzoic acid is cleared inefficiently by the immature neonatal liver. That history is why benzyl-alcohol-preserved injectable products carry neonatal warnings in their reference labeling, with the exact wording differing by product and region. It is background about pharmaceutical products, not usage guidance: the reagent sold here is a laboratory reconstitution material and is not for administration to any person or animal.

Can bacteriostatic water be used in cell-culture or in-vitro experiments?

Generally not recommended. Benzyl alcohol has documented cytotoxic effects on cultured cells even at low concentrations; one in vitro study reported measurable damage to cultured retinal pigment epithelial cells within two hours at concentrations well below 0.9% (PMID 18420195). For cell-based work, a preservative-free sterile water or a defined buffer is the more appropriate diluent. Bacteriostatic water is formulated for multidose peptide reconstitution, not cell culture.

Do all research peptides dissolve well in bacteriostatic water, or do some need a different diluent?

The right diluent is sequence-, counterion-, concentration- and formulation-specific, so no single rule fits every peptide. Depending on those factors, the supplier datasheet may specify sterile water, a defined buffer, dilute acid, dilute base or an organic solvent. Follow the exact instruction for the specific peptide, since a pH or solubility mismatch is a common cause of a cloudy or flaky solution.

Does the benzyl alcohol preservative itself degrade the peptide being reconstituted?

It depends on the specific peptide. Some peptides are documented as sensitive to benzyl alcohol and can aggregate in its presence, while others are handled in benzyl-alcohol-preserved diluents without a reported problem. This is exactly why suppliers such as GenScript and Bachem publish peptide-specific handling guidance rather than one universal rule. When a peptide's own datasheet flags benzyl alcohol sensitivity, a preservative-free alternative is the appropriate diluent.

What batch documentation comes with bacteriostatic water, and is it independently tested?

The product has one database document: a Janoshik analysis for batch Blue submitted by the manufacturer. It is laboratory-issued, manufacturer-submitted documentation, not a shop-commissioned independent test. It is listed on /coa; match the batch identifier on the vial to the document before relying on it. Water is not one of the products for which the shop commissioned an independent lab report.

What is a syringe and needle used for with bacteriostatic water, if not injection into a person?

In a laboratory context, a syringe and needle are used to withdraw a measured volume of bacteriostatic water and transfer it into a lyophilised peptide vial for reconstitution, exactly as the protocol above describes. These are laboratory reconstitution and handling tools for preparing a solution for research use, not devices marketed or intended for administering any substance into a person or animal. They are sold strictly as research equipment for in-vitro laboratory work.

What does the USP designation mean on a bacteriostatic water label?

USP stands for United States Pharmacopeia, which publishes official quality standards, called monographs, for pharmaceutical materials. A product labeled as meeting the USP monograph for Bacteriostatic Water for Injection is claiming compliance with that monograph's requirements, which permit one or more suitable antimicrobial agents rather than fixing a single preservative or concentration, alongside pH, sterility and non-pyrogenicity requirements. It is a quality benchmark for the material itself, not an approval of any specific commercial product and not a claim about its regulatory status in the EU.

Can one vial of bacteriostatic water be used to reconstitute more than one peptide?

Yes. A manufacturer-designated multidose vial can supply multiple peptide vials, but every access must use a new sterile needle and a new sterile syringe with aseptic technique. Keep it within the applicable post-puncture period (the general convention is 28 days unless the manufacturer specifies otherwise), and discard it sooner if sterility is compromised or questionable. Many laboratories dedicate one diluent vial per peptide or short project to simplify records and reduce cross-contamination risk; follow the laboratory's validated protocol and the vial documentation.

What happens if a vial of bacteriostatic water freezes during shipping or storage?

Freezing falls outside the labeled storage conditions and is an out-of-specification temperature excursion. A frozen vial should be quarantined and assessed with the manufacturer or supplier rather than used on the assumption that it is fine: visual clarity alone cannot establish container integrity, sterility or preservative performance. Freezing can also stress the vial-to-stopper seal. If a vial arrives visibly frozen, cracked, or stays cloudy after reaching room temperature, treat it as a shipping-damage case.

How does bacteriostatic water compare to dilute acetic acid as a reconstitution diluent?

Bacteriostatic water is a benzyl-alcohol-preserved aqueous diluent; dilute acetic acid is an acidic solvent and is not a validated multidose preservative system. Suitability depends on the peptide's sequence, counterion, target concentration and formulation, so follow the specific supplier datasheet rather than a peptide-class default. The comparison guide, bacteriostatic water vs acetic acid vs sterile water, explains those decision factors.

Bacteriostatic Water for Peptide Reconstitution: Benzyl Alcohol, pH and Multidose Use

Q: Why does bacteriostatic water usually come in a glass vial rather than plastic?

Rubber-stoppered glass vials are common because glass is chemically inert and holds a reliable seal across repeated needle punctures, but pharmacopoeias do not require glass specifically: some approved products ship in a semi-rigid polyolefin plastic vial. What matters is a validated, sealed container-closure system compatible with the formulation. A plain, non-sealed bottle without a preservative claim is a signal to check the documentation before use.

Bacteriostatic water is the quiet workhorse of peptide research. It is not glamorous, and many researchers order it alongside peptide vials. The diluent is one factor in the usable life and microbial control of a reconstituted peptide solution; the peptide, formulation, handling and storage conditions also matter. The diluent itself should match the specification required by the peptide's documentation and the laboratory protocol.

Laboratory reagent only

The bacteriostatic water sold here is supplied as a laboratory reconstitution reagent for research use only. It is not a medicine and is not intended for administration to any person or animal. The regulatory and clinical references below describe the pharmaceutical product and its history; they are background, not usage guidance for this reagent.

Bacteriostatic Wateraccessories

USP-grade sterile water with 0.9% benzyl alcohol (near-neutral, ~pH 6) - the standard solvent for reconstituting lyophilized peptides. Essential accessory for any peptide research. Each vial is sealed and ready to use.

What Is Bacteriostatic Water?

Bacteriostatic water for injection (BWFI) is sterile water containing an added antimicrobial preservative, most commonly benzyl alcohol at 0.9% (9 mg/mL), with some products using 1.1% (11 mg/mL). In the pharmaceutical reference product (for example the Pfizer labeling), the solution has a pH around 5.7 (range 4.5 to 7.0) and is labeled as a diluent for parenteral drugs after reconstitution. That labeled use describes the medical product; the reagent sold here is for laboratory reconstitution, not administration.

The decisive word is bacteriostatic, not bactericidal. Benzyl alcohol is included to inhibit microbial growth, not to sterilise a contaminated vial. Repeated entry into a manufacturer-designated multidose vial still requires a new sterile needle and a new sterile syringe for every access, plus aseptic handling. USP General Chapter <797> and CDC use a general 28-day post-puncture discard convention unless the manufacturer specifies another period.

Why 0.9% Benzyl Alcohol?

The 0.9% figure is the concentration used by the common reference product, not a single value that the pharmacopoeia mandates. The USP monograph for Bacteriostatic Water for Injection permits one or more suitable antimicrobial agents rather than fixing one preservative or concentration, and official products appear at both 0.9% and 1.1% benzyl alcohol. In practice 0.9% is the formulation most peptide-reconstitution protocols reference.

Plain sterile water without preservative behaves differently: a broached vial is treated as single-use, because it carries no agent to limit microbial growth between punctures. That is the practical reason a preserved diluent is preferred for a vial that will be entered several times.

Common Reference Specification

Typical 0.9% bacteriostatic water for injection (Pfizer reference): 0.9% (9 mg/mL) benzyl alcohol, pH target 5.7 (range 4.5-7.0), sterile, non-pyrogenic, multidose container. Some pharmaceutical diluents instead use 1.1% benzyl alcohol. The reference labels describe a multidose container requiring aseptic technique; the widely used 28-day figure comes from the general USP General Chapter <797> and CDC discard convention for opened multidose vials, not from a fixed number in the water monograph itself. Source: Pfizer bacteriostatic water labeling and the USP monograph for Bacteriostatic Water for Injection.

Why Benzyl Alcohol Formulations Carry a Neonatal Warning (Historical Background)

This section is historical and regulatory background on the benzyl alcohol preservative, not usage guidance for the reagent sold here. In 1982, the CDC published an MMWR report describing a cluster of neonatal deaths linked to flush solutions containing benzyl alcohol. The clinical picture, metabolic acidosis, respiratory failure, hypotension and a distinctive agonal breathing pattern, was called Gasping Syndrome.

The mechanism was later tied to benzyl alcohol metabolism into benzoic acid, which premature neonates cannot efficiently conjugate and clear. The parallel NEJM publication by Gershanik and colleagues (NEJM 1982; 307:1384-8) documented affected infants and became the pharmacovigilance anchor for later benzyl alcohol label warnings.

Regulators treat this differently by product and region: US labeling for benzyl-alcohol-preserved water contraindicates neonatal use, while current European product information generally places neonatal and paediatric concerns under warnings and quantified exposure limits rather than an identical contraindication. That history is why benzyl-alcohol-preserved diluents carry the warnings they do.

What this means for the reagent here

The bacteriostatic water sold here is a laboratory reconstitution reagent and is not intended for administration to any person or animal, so the neonatal history above is context rather than a use instruction. The point researchers take from it is simply that benzyl alcohol is a preservative with a documented toxicology profile, which is one reason a preservative-free diluent is chosen for applications where benzyl alcohol is unsuitable.

BAC Water vs. Sterile Water for Injection

The two labels look similar and are regularly confused, but they are not interchangeable.

Property	Bacteriostatic Water	Sterile Water for Injection
Preservative	Commonly 0.9% benzyl alcohol	None
Multidose use	Yes, with a post-puncture discard convention	No, single-entry only
pH	4.5-7.0	5.0-7.0
Typical lab role	Multidose reconstitution	Single-entry dilutions

Preservative

Bacteriostatic Water: Commonly 0.9% benzyl alcohol
Sterile Water for Injection: None

Multidose use

Bacteriostatic Water: Yes, with a post-puncture discard convention
Sterile Water for Injection: No, single-entry only

Bacteriostatic Water: 4.5-7.0
Sterile Water for Injection: 5.0-7.0

Typical lab role

Bacteriostatic Water: Multidose reconstitution
Sterile Water for Injection: Single-entry dilutions

For lyophilised peptides reconstituted across several draws, bacteriostatic water is the common choice of diluent. For single-entry preparations, or when benzyl alcohol is unsuitable for the application, preservative-free sterile water for injection is used instead. (A separate category, "bactericidal water", refers to various product-specific antimicrobial formulations and is not a single standardised composition, so it is not compared here.)

Peptide Stability After Reconstitution

The diluent is only half of the stability equation. Once reconstituted, peptide solutions are sensitive to temperature, light and repeated temperature cycling. Importantly, the water vial's post-puncture discard convention says nothing about how long the resulting peptide solution stays chemically stable: that depends on the specific peptide and must come from peptide-specific validated stability data, not from the diluent.

Supplier guidance does not converge on a single universal rule. GenScript recommends that, when storage in solution is unavoidable, peptide solutions be aliquoted and stored at -20 °C; Bachem recommends aliquots frozen below -15 °C and states that no single solubilisation protocol fits every peptide. Light protection and freeze-thaw limits are peptide- and formulation-specific. Follow the peptide supplier's datasheet and use single-use aliquots when its validated guidance calls for frozen storage.

Storage After Reconstitution

Follow the specific peptide's own validated storage and stability guidance rather than a generic figure. As general practice, reconstituted solutions are protected from light and freeze-thaw cycling, and any solution is treated as a working solution whose usable life is set by peptide-specific data, not by the water vial's discard convention.

Quality Criteria

Not every bottle labelled "bacteriostatic water" meets pharmacopoeial standards. Three markers separate a research-grade product from a dubious one.

First, the label should identify every antimicrobial preservative and its concentration. If the product claims compliance with a named USP, Ph. Eur. or BP monograph, the batch documentation should support that exact claim; those pharmacopoeial designations are not interchangeable.

Second, the container must be a validated, sealed container-closure system compatible with the formulation (rubber-stoppered vials are common; pharmacopoeias do not require glass specifically, and some approved products ship in a semi-rigid polyolefin plastic vial). A plain, non-sealed bottle without a preservative claim is usually not bacteriostatic water.

Third, a production lot should have a batch number, an expiry date, and batch-specific documentation whose issuer and submission source are identified. Such a document is manufacturer-provided specification or analysis material, not an independent third-party test commissioned by the shop.

Practical Use: Reconstitution Basics

Bacteriostatic water is almost always used to dissolve a lyophilised peptide. The procedure matters more than most researchers assume: vigorous handling can introduce foam and air-liquid interfaces and can promote aggregation in susceptible formulations.

Equilibrate as the product documentation directs

Allow the lyophilised peptide vial to reach room temperature before opening, as its datasheet directs, to reduce condensation on the cold cake. Keep the water within its labeled storage conditions; do not impose a fixed equilibration time unless its documentation specifies one.

Disinfect both stoppers

Wipe the rubber stoppers of both vials with 70% isopropyl alcohol. Let the alcohol evaporate before inserting a needle.

Draw the calculated volume of bacteriostatic water

Use a new sterile needle and a new sterile syringe to withdraw the volume your protocol specifies. The volume follows from your target concentration, the peptide's solubility data and your protocol, not from a fixed default. Add the water slowly down the inside wall of the peptide vial, not directly onto the powder.

Swirl, do not shake

Roll or gently swirl the vial until the cake fully dissolves. Vigorous agitation introduces air and can promote foaming, interfacial stress or aggregation in some peptide formulations.

Store per the peptide's own guidance and log the date

Store the reconstituted vial as the specific peptide's validated guidance directs, protected from light, and write the reconstitution date on the label. Set the usable life from peptide-specific stability data; separately, the water vial itself follows the general multidose discard convention once punctured.

EU Shipping

For researchers in the European Union, sourcing bacteriostatic water from within the EU avoids import clearance for destinations inside the EU customs territory and may shorten transit. PeptidesDirect ships from within the EU with tracking; see the shipping page for current destination-specific estimates. A manufacturer-submitted Janoshik analysis document is available for batch Blue; this is manufacturer-provided documentation, not independent third-party testing commissioned by the shop.

Summary

Bacteriostatic water is not a generic accessory. It is a specified formulation with a common preservative concentration (0.9% benzyl alcohol, with 1.1% products also in use), a defined pH (around 5.7), a multidose container design and a general 28-day post-puncture discard convention unless the manufacturer specifies another period, and a well-documented preservative toxicology profile behind the neonatal warnings on the reference drug product. As a laboratory reagent it is a controlled, specified diluent rather than plain sterile water, which is what keeps peptide reconstitution reproducible across multiple draws.

Frequently Asked Questions